The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study

ConclusionNSBB therapy was associated with longer survival in PP and SP groups who had an advanced stage of cirrhosis. Moreover, low-dose NSBB exhibited a better benefit than a standard-titrated high-dose NSBB with better tolerability.
Source: Hepatology International - Category: Infectious Diseases Source Type: research